This company has been marked as potentially delisted and may not be actively trading. OTCMKTS:KIPS (KIPS) (KIPS) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About (KIPS) Stock (OTCMKTS:KIPS) 30 days 90 days 365 days Advanced Chart Get (KIPS) alerts:Sign Up Key Stats Today's Range$0.0071▼$0.007150-Day Range N/A52-Week Range$0.01▼$0.30VolumeN/AAverage Volume69,500 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Kips Bay Medical, Inc. is a medical device company. The Company is focused on developing, manufacturing and commercializing its external saphenous vein support technology, the eSVS Mesh, for use in coronary artery bypass (CABG) surgery. Its eSVS Mesh is designed to be fitted like a sleeve on the outside of saphenous vein grafts (SVG or vein graft) to strengthen SVGs used in CABG surgery. The eSVS Mesh provides vein grafts with physical attributes similar to those of an artery. Its eSVS Mesh is designed for reducing the lumen diameter and improving blood flow characteristics. Its eSVS Mesh technology consists of the eSVS Mesh (25 centimeter length, and either 3.5, 4.0 or 4.5 millimeter in diameter); delivery tube for use in placing its eSVS Mesh on the saphenous vein (color-coded, one for each diameter of its eSVS Mesh); suture snare for use in loading its eSVS Mesh onto the saphenous vein, and sizing tool for use in choosing the correct device size based on saphenous vein diameter. Read More Receive KIPS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (KIPS) and its competitors with MarketBeat's FREE daily newsletter. Email Address KIPS Stock News HeadlinesMANSION MAKEOVER | Inside an Enchanting Tea RoomJune 19, 2025 | msn.comTLC driver crashes into and collapses Manhattan scaffoldJune 17, 2025 | msn.comI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.July 2 at 2:00 AM | Porter & Company (Ad)MTA bus operator fatally hits man crossing Manhattan streetJune 16, 2025 | msn.comPedestrian fatally struck by MTA bus in Kips Bay: NYPDJune 16, 2025 | msn.comWWE's Damian Priest Shares Pics From NYC Puerto Rican Day ParadeJune 11, 2025 | msn.comEXTREME ROOM MAKEOVER | Inside an Amazing New York City MansionJune 7, 2025 | msn.comHOME TRANSFORMATION | Amazing Dining Room RemodelJune 4, 2025 | msn.comSee More Headlines KIPS Stock Analysis - Frequently Asked Questions What other stocks do shareholders of (KIPS) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (KIPS) investors own include Netflix (NFLX), Solidcore Resources (POLY), RELX (RELX), boohoo group (BOO), Barratt Developments (BDEV), Barclays (BARC) and Alibaba Group (BABA). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorN/A Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:KIPS CIK1460198 Webwww.kipsbaymedical.com Phone+1-763-2353540FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (OTCMKTS:KIPS) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (KIPS) Please log in to your account or sign up in order to add this asset to your watchlist. Share (KIPS) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.